Jefferies analyst Matthew Stanton lowered the price target on Repligen (NASDAQ: RGEN) to $170.00 (from $180.00) while maintaining a Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE